• Home
        •  | 
        • Partners log-in
      • About Cupron
        • News & Events
        • In the media
        • Cupron Management
        • Regulation
        • FAQ
        • Contact
      • Markets
        • Consumer
        • Industrial
        • Medical
        • Military
      • Cupron Technology
        • The Power of Copper
        • The Cupron Difference
        • Safety Testing
        • The Environment
        • Scientific Data
      • Manufacturing
        • Manufacturing Process
        • Different Substrates
    • The Power of Copper
    •  The Cupron Difference
    • Safety Testing
    • The Environment
    • Scientific Data
    • Home
    •  › 
    • Cupron Technology
    •  › 
    • The Cupron Difference
    •  › 
    • Broad spectrum effectiveness against bacteria, viruses, mold, and dustmites

    Broad spectrum effectiveness against bacteria, viruses, mold, and dustmites

     

    Independent, clinical, and in-house testing have consistently demonstrated Cupron technolog's effectiveness against a broad range of microorganisms in the medical arena. These include, but are not limited, to those identified in the following table:

    Organism

    % Reduction**

    Fungus

     

    Tricophyton mentagrophytes (foot fungus)

    >99.9

    Tricophyton rubrum

    >99.9

    Candida albicans

    >99.9

    Aspergillus niger

    >99.9

    Bacteria

     

    Pseudomonas aeruginosa

    >99.9

    Enterococcus faecalis (VRE)

    >99.9

    Escherichia coli (E. coli)

    >99.9

    Listeria

    >99.9

    Klebsiella pneumonia

    >99.9

    Acinetobacter baumannii

    >99.9

    Staphylococcus aureus (MRSA)

    >99.9

    Salmonella cholersuis

    >99.9

    Virus

     

    HIV 1

    >99.9

    Measles

    >99.9

    Influenza (H1N1) (Swine flu)

    >99.9

    Influenza (H9N2) (Bird flu)

    >99.9

     

     

        ** test data on file. This data exclusively applies to medical devices.

     

     

    1.      Borkow, G., and Gabbay, J. (2004) Putting copper into action: copper impregnated products with

             potent biocidal activities. FASEB Journal. 18: 1728-1730.

    2.      Borkow, G., and Gabbay, J. (2006) Endowing textiles with permanent potent biocidal properties

             by impregnating them with copper oxide. Journal of Textile and Apparel, Technology and

             Management. 5(1) 

     

    3.      Gabbay, J., Mishal, J., Magen, E., Zatcoff, R., Shemer-Avni, Y., and Borkow, G. (2006) Copper oxide

     

             impregnated textiles with potent biocidal activities. Journal of Industrial Textiles. 35(4):323-335.

    4.      Borkow, G., Sidwell, R.W., Smee, D.F., Barnard, D.L., Morrey, J.D., Lara-Villegas, H.H., Shemer-Avni,

     

             Y., and Gabbay, J. (2007) Neutralizing viruses by copper oxide based filters. Antimicrobial Agents

     

             and Chemotherapy, 51(7): 2605-2607.

     

    5.      Borkow, G., Lara, H.H., Covington, C.Y., Nyamathi, A., and Gabbay, J. (2008) Deactivation of HIV-1

     

             in medium by copper-oxide containing filters. Antimicrobial Agents and Chemotherapy 52(2):518-525.

     

    6.      Mumcuoglu, K.Y., Gabbay, J., and Borkow, G. (2008) Copper oxide impregnated fabrics for the control

     

             of house dust mites. International Journal of Pest Management 54(3):235- 240.

     

     

     

      

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    •  
      • © Copyright Cupron 2008, All rights reserved.
        • Cupron
        •   |  
        • About Cupron
        •   |  
        • Markets
        •   |  
        • The Power of Copper
        •   |  
        • FAQ
        •   |  
        • Cupron Technology
        •   |  
        • Manufacturing

      • Product claims that can be made for products containing Cupron technology vary by country and by product. In particular, all antimicrobial claims in the US
        are strictly regulated by the US EPA, which allows only preservative "treated article" claims, while structure-function/disease-treatment claims in the US need
        to be pre-market approved by the US FDA. Partners and customers should consult Cupron for all questions regarding product claims in particular countries

    •